Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

2008 China Biopharma M&A Deals Running Ahead of 2007

publication date: Dec 17, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

According to data developed by our sister organization, ChinaBio® Consulting, there were more M&A deals in China biopharma during the first 10 months of 2008 than in all of 2007.  The dollar value is also higher this year. However, the average deal size has dropped from $41.7 million last year to $25 million in 2008.  More details...

Stock Symbols: (NYSE: WX) (NYSE: MR) (NSDQ: DSCP)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...